Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Hackensack Meridian Health
University of Chicago
BeOne Medicines
University of Washington
AstraZeneca
Hoffmann-La Roche
Dana-Farber Cancer Institute
Acerta Pharma BV
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University of California, San Diego
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Miami
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
MingSight Pharmaceuticals, Inc
Memorial Sloan Kettering Cancer Center
Aprea Therapeutics
University of Rochester
Academic and Community Cancer Research United
University of Rochester
OrphAI Therapeutics
University of California, San Diego
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Altor BioScience
M.D. Anderson Cancer Center
Pfizer
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Eastern Cooperative Oncology Group
Celgene
Hoffmann-La Roche
M.D. Anderson Cancer Center
University of Nebraska
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of Wisconsin, Madison